Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CATERPILLAR-study protocol: an assessor-blinded randomised controlled trial comparing taurolidine-citrate-heparin to heparin-only lock solutions for the prevention of central line-associated bloodstream infections in paediatric oncology patients.
van den Bosch CH, Loeffen Y, van der Steeg AFW, van der Bruggen JT, Frakking FNJ, Fiocco M, van de Ven CP, Wijnen MHWA, van de Wetering MD. van den Bosch CH, et al. Among authors: van der bruggen jt. BMJ Open. 2023 Mar 21;13(3):e069760. doi: 10.1136/bmjopen-2022-069760. BMJ Open. 2023. PMID: 36944461 Free PMC article.
Incidence, severity and outcome of central line related complications in pediatric oncology patients; A single center study.
van den Bosch CH, van der Bruggen JT, Frakking FNJ, Terwisscha van Scheltinga CEJ, van de Ven CP, van Grotel M, Wellens LM, Loeffen YGT, Fiocco M, Wijnen MHWA. van den Bosch CH, et al. Among authors: van der bruggen jt. J Pediatr Surg. 2019 Sep;54(9):1894-1900. doi: 10.1016/j.jpedsurg.2018.10.054. Epub 2018 Oct 30. J Pediatr Surg. 2019. PMID: 30415957 Free article.
The efficacy of taurolidine containing lock solutions for the prevention of central-venous-catheter-related bloodstream infections: a systematic review and meta-analysis.
van den Bosch CH, Jeremiasse B, van der Bruggen JT, Frakking FNJ, Loeffen YGT, van de Ven CP, van der Steeg AFW, Fiocco MF, van de Wetering MD, Wijnen MHWA. van den Bosch CH, et al. Among authors: van der bruggen jt. J Hosp Infect. 2022 May;123:143-155. doi: 10.1016/j.jhin.2021.10.022. Epub 2021 Nov 9. J Hosp Infect. 2022. PMID: 34767871 Free article. Review.
The applicability of the central line-associated bloodstream infection (CLABSI) criteria for the evaluation of bacteremia episodes in pediatric oncology patients.
van den Bosch CH, Frakking FNJ, Loeffen YGT, van Tinteren H, van der Steeg AFW, Wijnen MHWA, van de Wetering MD, van der Bruggen JT. van den Bosch CH, et al. Among authors: van der bruggen jt. Eur J Haematol. 2024 May;112(5):832-839. doi: 10.1111/ejh.14175. Epub 2024 Jan 31. Eur J Haematol. 2024. PMID: 38294085
The effect of taurolidine on the time-to-positivity of blood cultures.
van den Bosch CH, Moree JEP, Peeters S, Lankheet M, van der Steeg AFW, Wijnen MHWA, van de Wetering MD, van der Bruggen JT. van den Bosch CH, et al. Among authors: van der bruggen jt. Infect Prev Pract. 2024 Feb 29;6(2):100352. doi: 10.1016/j.infpip.2024.100352. eCollection 2024 Jun. Infect Prev Pract. 2024. PMID: 38510847 Free PMC article.
The CATERPILLAR study: an assessor-blinded randomized controlled trial comparing a taurolidine-citrate-heparin lock solution to a heparin-only lock solution for the prevention of central-line-associated bloodstream infections in paediatric oncology patients.
van den Bosch CH, Loeffen YGT, van der Steeg AFW, van der Bruggen JT, Frakking FNJ, Fiocco M, van de Ven CP, Wijnen MHWA, van de Wetering MD. van den Bosch CH, et al. Among authors: van der bruggen jt. J Hosp Infect. 2024 Oct;152:56-65. doi: 10.1016/j.jhin.2024.06.009. Epub 2024 Jul 14. J Hosp Infect. 2024. PMID: 39004189 Free article. Clinical Trial.
Disseminated nontuberculous mycobacterial infections after allogeneic hematopoietic stem cell transplantation: a risk-based strategy for early diagnosis.
Daenen LGM, van der Bruggen JT, Leguit RJ, van der Wagen LE, van Rhenen A, Wunderink HF, de Witte MA, Bruns AHW, Kuball J. Daenen LGM, et al. Among authors: van der bruggen jt. Bone Marrow Transplant. 2023 Aug;58(8):956-958. doi: 10.1038/s41409-023-02011-6. Epub 2023 May 20. Bone Marrow Transplant. 2023. PMID: 37210471 No abstract available.
Priorities for antibiotic resistance surveillance in Europe.
Fluit AC, van der Bruggen JT, Aarestrup FM, Verhoef J, Jansen WT. Fluit AC, et al. Among authors: van der bruggen jt. Clin Microbiol Infect. 2006 May;12(5):410-7. doi: 10.1111/j.1469-0691.2006.01406.x. Clin Microbiol Infect. 2006. PMID: 16643516 Free article. Review.